Our results demonstrate that plasma endocan concentrations measured early in the course of ARDS can reflect disease severity and predict poor evolution, as assessed by death or prolonged dependence on mechanical ventilation. The gene discussed is ESM1; the disease is acute respiratory distress syndrome.